Polar Capital Healthcare Blue Chip Fund

Select share classes

Polar Capital Funds PLC - Polar Capital Healthcare Blue Chip Fund I Income

Category Sector Equity Healthcare
star-filledstar-filledstar-filledstar-filled
This fund can be held in an Investment ISA, SIPP and Investment Account
Last buy/sell price

£13.51/£13.51

arrow-down£-0.04 (-0.30%)

Fund Code

POHBI

BPRBXT0

IE00BPRBXT06

Prices updated as at 15 Apr 2025
|
Prices in GBP
Investment objective
The Fund’s investment objective is to achieve long term capital appreciation.
Important notice: This product is based overseas and is not subject to UK sustainable investment labelling and disclosure requirements. Please refer to the FCA website which details further information in relation to sustainability disclosure requirements for retail clients.
Important documents: Please ensure that you have read the Key Information Document/Technical Guide
, Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and the fund information documents. These can be found within the Charges & documents section.

Portfolio as of 28/02/2025

Asset allocation

Created with Highcharts 7.2.299.78% Stocks- Bonds0.22% Cash- Other- Not classified
Show long & short position

Geographical breakdown

Continent or country allocation (%)

Created with Highcharts 7.2.22.212.214.294.2916.816.825.8125.8150.8950.89United KingdomJapanEurozoneEurope - ex EuroUnited States

Market classification (%)

Created with Highcharts 7.2.2100100EmergingDeveloped

Stock style

Large growth

35.79%

% Weight
Value
Core
Growth
Large

11

14

36

Medium

3

6

17

Small

1

8

5

Valuation

Polar Capital Funds PLC - Polar Capital Healthcare Blue Chip Fund I Income
Sector Equity Healthcare

20.78

20.78
19.46

1.77

1.77
1.89

3.58

3.58
4.28

17.90

17.90
16.54

Growth rate

Polar Capital Funds PLC - Polar Capital Healthcare Blue Chip Fund I Income
Sector Equity Healthcare

13.67%

13.67%
10.42%

1.06%

1.06%
1.36%

3.48%

3.48%
2.10%

Top 10 holdings

1
Eli Lilly and Co
Sector
-
Country
United States
% of assets
9.35163
2
UnitedHealth Group Inc
Sector
-
Country
United States
% of assets
7.65504
3
Novo Nordisk AS Class B
Sector
-
Country
Denmark
% of assets
6.38221
4
Abbott Laboratories
Sector
-
Country
United States
% of assets
5.58392
5
Roche Holding AG
Sector
-
Country
Switzerland
% of assets
4.39458
6
UCB SA
Sector
-
Country
Belgium
% of assets
4.31377
7
Intuitive Surgical Inc
Sector
-
Country
United States
% of assets
4.08371
8
Sanofi SA
Sector
-
Country
France
% of assets
3.72038
9
DexCom Inc
Sector
-
Country
United States
% of assets
3.68328
10
Fresenius SE & Co KGaA
Sector
-
Country
Germany
% of assets
3.48152
Assets in top 10 holdings %

52.65%

Total no. of equity holdings

32.00

Total no. of bond holdings

-

Stock sectors

Polar Capital Funds PLC - Polar Capital Healthcare Blue Chip Fund I Income
Sector Equity Healthcare

0.00%

Basic materials

-
-

Con cyclical

-
-

Financial svs

-
-

Real estate

-
-

0.00%

Comm services

-
-

Energy

-
-

Industrials

-
-

Technology

-
-

100.00%

Con defensive

-
-

Healthcare

100.00%
-

Utilities

-
-


Important Information

Please note the value of investments can go down as well as up so you may get back less than you invested. This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to an authorised financial adviser. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and(3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.


Any ESG-related information, methodologies, tools, ratings, data and opinions contained or reflected herein are not directed to or intended for use or distribution to India-based clients or users and their distribution to Indian resident individuals or entities is not permitted, and Morningstar accepts no responsibility or liability whatsoever for the actions of third parties in this respect.
© Copyright 2025 Morningstar. All rights reserved.